Industries > Pharma > Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019

Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019

Branded Drugs, Generic Drugs, Leading Companies

PUBLISHED: 28 June 2019
PAGES: 253
PRODUCT CODE: PHA0454
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0454 Categories: , Tags: , , ,

The pharmaceutical wholesale and distribution market is vital, providing access to life saving drugs to vast number of people in a timely manner. The market is large, with many opportunities for growth and development during the forecast period.

The establishment of the pharmaceutical wholesale market was driven by manufacturers wanting to outsource distribution to wholesalers to focus on core competencies of R&D and marketing. At the same time, hospitals outsourced inventory management in an effort to reduce investment in this area. These factors created a high demand for a comprehensive wholesale and distribution service.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 253-page report you will receive 157 charts– all unavailable elsewhere.

The 253-page report provides clear detailed insight into the leading pharmaceutical wholesale & distribution organizations. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharmaceutical Wholesale & Distribution Market Size Forecast from 2019-2029

• Global Pharmaceutical Wholesale & Distribution Market Size Forecast from 2019-2029 segmented by submarket:
• Branded Drugs
• Generic Drugs
• Others

• A SWOT and STEP analysis of the global pharmaceutical wholesale & distribution market

• Profiles of the 30 leading pharmaceutical wholesale & distribution organizations:
• Alfresa Holdings
• AmerisourceBergen
• Anda Inc.
• Auburn Pharmaceutical Company
• Capital Wholesale Drug Company
• Cardinal Health
• CR Pharmaceutical
• CuraScript Special
• Dakota Drug, Inc.
• Fff Enterprises Inc.
• Fortissa Limited
• HyGen Pharmaceuticals Inc.
• Kingworld Medicines Group Ltd.
• Mawdsley-Brooks & Co. Ltd.
• McKesson
• MEDIPAL HOLDINGS
• Morris & Dickson Co. LLC
• North Carolina Mutual Wholesale Drug
• Ohki Health Care Holdings, Inc.
• Prodigy Health
• Profarma Distribuidora de Produtos Farmaceuticos SA
• Realcan Pharmaceutical Group Co., Ltd
• Rochester Drug Cooperative
• Shanghai Pharmaceutical Holdings.
• SINOPHARM
• Smith Drug Company
• SUZUKEN
• The PHOENIX Group
• Walgreens Boots Alliance
• Zhejiang Intl Group Co., Ltd.

Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019

• The content of each profile differs, depending on the organization. In general, a profile gives the following information:
• Overview of the company’s services and operations
• Analysis of recent financial performance – annual revenue for services, including data on operating profit and margins
• Revenue forecast from 2019 to 2029
• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations
Sales Force Structure

• Key Questions Answered by this Report:
• How is the pharmaceutical wholesale and distribution drug market evolving?
• What is driving and restraining the pharmaceutical wholesale and distribution industry?
• What are the market shares of main segments of the world pharmaceutical wholesale and distribution market?
• How will each submarket grow over the forecast period and how much revenue will these segments account for in 2029?
• How will the market shares for pharmaceutical wholesale and distribution submarkets develop from 2018 to 2029?
• What will be the main sales drivers for the overall market and components from 2018-2029?
• How will political and regulatory events influence regional markets and submarkets?
• How will the market shares of top national markets change from 2018 and which geographical region will lead the market in 2029?
• Who are the leading companies and what are their revenue prospects over the forecast period to 2029?
• What are the trends for M&A activity, consolidation for existing players and the prospects for new market entrants?
• How will that industry evolve between 2018 and 2029? Where does it head and what forces change it?

Visiongain’s study is intended for anyone requiring commercial analyses for pharmaceutical wholesale & distribution market. You find data, trends and predictions.

Buy our report today Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019: Branded Drugs, Generic Drugs, Leading Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019


Download sample pages

Complete the form below to download your free sample pages for Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019


Latest Pharma news

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019

READ

“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019

READ

“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019

READ

“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019

READ

Categories

Category